Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. (MeCOVID)
Multicenter Randomized Controlled Trial of the Efficacy of Melatonin in the Prophylaxis of SARS-coronavirus-2 Infection Among High Risk Contacts.
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Listed as NCT04353128, this PHASE2/PHASE3 trial focuses on Coronavirus Infection and Covid19 and remains completed. Sponsored by Instituto de Investigación Hospital Universitario La Paz, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
-
Jan 2021 — Dec 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
May 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto de Investigación Hospital Universitario La Paz
For direct contact, visit the study record on ClinicalTrials.gov .